VH · Heavy chain variable region121 aa
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSSPUBLIC ANTIBODY SEQUENCE · PSC-BCMA-009
Belantamab antibody sequence
BCMA / CD269 · TNFRSF17
A reference sequence for the growing field of BCMA-targeted drugs, cell therapy and ADC internalization research.
Public variable-region amino-acid sequences
The sequences below cover the VH and VL variable regions. They do not include the constant region, signal peptide or other engineered design selected for a customer project.
VL · Light chain variable region107 aa
DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKVEIKPUBLIC SOURCEThera-SAbDab PL132 · Approved / Active (Feb 2025)
View the original Thera-SAbDab record Suggested research applications
- BCMA binding detection
- Plasma-cell phenotyping
- Internalization studies
- ADC method development
Suggested starting labels
SF488SF594PEAPC
Dye selection can be adjusted for instrument lasers, co-expression intensity and panel design. Final selection is confirmed during project assessment.
Optional project scope
- Sequence review and construct design
- Recombinant expression and purification
- Fluorescent conjugation and free-dye removal
- Concentration, appearance and agreed basic quality checks
START FROM THIS SEQUENCE
Start a project from this public sequence
Submit the intended antibody format, scale, fluorophore and application. We will first confirm the technical route and delivery boundaries.